Spero Therapeutics Inc (SPRO)
1.24
-0.07
(-5.34%)
USD |
NASDAQ |
Nov 14, 12:44
Spero Therapeutics Total Assets (Quarterly): 149.88M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 149.88M |
| March 31, 2024 | 167.70M |
| December 31, 2023 | 182.39M |
| September 30, 2023 | 107.10M |
| June 30, 2023 | 98.88M |
| March 31, 2023 | 112.55M |
| December 31, 2022 | 124.80M |
| September 30, 2022 | 64.48M |
| June 30, 2022 | 63.63M |
| March 31, 2022 | 145.83M |
| December 31, 2021 | 171.07M |
| September 30, 2021 | 144.69M |
| June 30, 2021 | 119.59M |
| March 31, 2021 | 143.44M |
| December 31, 2020 | 153.45M |
| Date | Value |
|---|---|
| September 30, 2020 | 157.04M |
| June 30, 2020 | 97.54M |
| March 31, 2020 | 109.89M |
| December 31, 2019 | 106.10M |
| September 30, 2019 | 112.51M |
| June 30, 2019 | 122.49M |
| March 31, 2019 | 124.65M |
| December 31, 2018 | 129.01M |
| September 30, 2018 | 136.12M |
| June 30, 2018 | 72.59M |
| March 31, 2018 | 81.06M |
| December 31, 2017 | 93.48M |
| September 30, 2017 | 31.55M |
| June 30, 2017 | 40.10M |
| December 31, 2016 | 13.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
63.63M
Minimum
Jun 2022
182.39M
Maximum
Dec 2023
127.37M
Average
124.80M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Arbutus Biopharma Corp | 140.44M |
| Equillium Inc | 42.86M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.38M |
| Shareholders Equity (Quarterly) | 80.50M |
| Current Ratio | 2.678 |